Work

P2857Increase in pulse rate with semaglutide did not result in increased adverse cardiac events in subjects with type 2 diabetes in the SUSTAIN 6 cardiovascular outcomes trial

Year: 2018

Type: article

Source: European Heart Journal

DOI: 10.1093/eurheartj/ehy565.p2857

Authors: J Seufert, M Nauck, J Rosenstock, T Hansen, H Vrazic, T Vilsboll

Institutions: University of Freiburg, St. Josef-Hospital, Ruhr University Bochum, Dallas Diabetes Research Center, Novo Nordisk (Denmark), Steno Diabetes Center Copenhagen

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Steno Diabetes Center Copenhagen, Novo Nordisk, Medizinische Fakultät der Albert-Ludwigs-Universität Freiburg

OpenAlex ID: W2889468175

FWCI: 0.547

Cites:

Cited by: 10

Related to: 10